Showing results (321-330 of 350) with videos related to
Sort By:
Pageof 35
Cancer Medicine|May 26, 2017
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemiaCristina Santoro, Isabella Sperduti, Roberto Latagliata, et al.Cell Death & Disease|June 22, 2021
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancerMichele Signore, Romina Alfonsi, Giulia Federici, et al.Molecular Cancer|April 1, 2025
C1Q+ TPP1+ macrophages promote colon cancer progression through SETD8-driven p53 methylationVeronica Veschi, Francesco Verona, Sebastiano Di Bella, et al.Tumori|February 18, 2015
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter studyMichele De Tursi, Consiglia Carella, Silverio Tomao, et al.Journal of Cachexia, Sarcopenia and Muscle|October 23, 2024
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational studyIlaria Trestini, Lorenzo Belluomini, Alessandra Dodi, et al.Lung Cancer (Amsterdam, Netherlands)|June 12, 2022
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) surveySara Pilotto, Alice Avancini, Jessica Menis, et al.Cancer Medicine|June 26, 2024
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatmentGuido Giordano, Michele Milella, Matteo Landriscina, et al.Scientific Reports|February 22, 2017
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancerMichele Milella, Italia Falcone, Fabiana Conciatori, et al.Central European Journal of Urology|April 17, 2023
Predictors of trainees' proficiency during the learning curve of robot-assisted radical prostatectomy at high- -volume institutions: results from a multicentric seriesUmberto Anceschi, Michele Morelli, Rocco Simone Flammia, et al.Journal of Cellular Physiology|July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life settingTeresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.Pageof 35